Peripheral blood mononuclear cells (PBMCs) obtained from healthy donors were labeled with 1 µmol/L carboxyfluorescein succinimidyl ester (CFSE; Thermo Fisher Scientific) according to the manufacturer's protocol. CFSE‐labeled PBMCs (1 × 105) were plated into 96‐well plates with transduced HSC‐3 cells (2 × 104) in RPMI medium supplemented with 10% FCS, 100 units/mL penicillin, and 100 μg/mL streptomycin. Following the addition of anti‐CD3/anti‐CD28 stimulus (Treg Suppression Inspector human; Miltenyi Biotec), the cells were incubated for 96 h. After incubation, floating cells were harvested and stained with allophycocyanin (APC)‐CD3 antibody (BD Bioscience) at 4°C for 1 h. Then, 7‐AAD (BD Bioscience) was added 10 min before the analysis. The proliferation of CD3‐positive 7‐AAD‐negative cells was measured by dilution of CFSE staining using flow cytometry.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.